Evidence supports the expression of brain-type sodium channels in the heart. Their functional role, however, remains controversial. We used global Na V 1.6-null mice to test the hypothesis that Na V 1.6 contributes to the maintenance of propagation in the myocardium and to excitation-contraction (EC) coupling. We demonstrated expression of transcripts encoding full-length Na V 1.6 in isolated ventricular myocytes and confirmed the striated pattern of Na V 1.6 fluorescence in myocytes. On the ECG, the PR and QRS intervals were prolonged in the null mice, and the Ca 2؉ transients were longer in the null cells. Under patch clamping, at holding potential (HP) ‫؍‬ ؊120 mV, the peak I Na was similar in both phenotypes. However, at HP ‫؍‬ ؊70 mV, the peak I Na was smaller in the nulls. In optical mapping, at 4 mM [K ؉ ] o , 17 null hearts showed slight (7%) reduction of ventricular conduction velocity (CV) compared to 16 wild-type hearts. At 12 mM [K ؉ ] o , CV was 25% slower in a subset of 9 null vs. 9 wild-type hearts. These results highlight the importance of neuronal sodium channels in the heart, whereby Na V 1.6 participates in EC coupling, and represents an intrinsic depolarizing reserve that contributes to excitation.-Noujaim, S. F., Kaur, K., Milstein, M., Jones, J. M., Furspan, P., Jiang, D., Auerbach, D. S., Herron, T., Meisler, M. H., Jalife, J. A null mutation of the neuronal sodium channel Na V 1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart. FASEB J. 26, 63-72 (2012). www.fasebj.org
ebellar atrophy, and ataxia; 3 additional heterozygotes in the same family exhibited milder cognitive and behavioral defects, including attention deficit hyperactivity disorder (5) . However, no studies have been reported to assess the possibility that mutation of Na V 1.6 produces adverse consequences in cardiac electrical function.
There are 9 genes for functional voltage-gated sodium-channel ␣ subunits in the human genome (6) . Several of these genes, including brain-type genes, are expressed in the heart, and the Na ϩ -channel subtypes are differentially localized and appear to have differences in functional properties (6, 7) . Structurally, Na ϩ channels are complexes of a ϳ260-kDa ␣ subunit in association with smaller ␤ subunits of 33-36 kDa (8) . The Na V 1.5 sodium-channel gene is strongly expressed in the heart, and for many years it was thought to be exclusively responsible for generating the upstroke of the normal cardiac action potential. However, it has recently become evident that neuronal and skeletal muscle Na ϩ -channel isoforms are also expressed at low levels in the heart and may contribute to cardiac function (3) . Immunolocalization studies have revealed distinct subcellular localization of the various ␣ and ␤ subunits, and it has been proposed that the primary Na ϩ channels in ventricular myocytes are composed of Na V 1.5 plus ␤2 and/or ␤4 subunits in intercalated disks, in addition to Na V 1.1, Na V 1.3, and Na V 1.6 plus ␤1 and/or ␤3 subunits in the transverse tubules (9, 10) . Functionally, brain-type Na ϩ channels are thought to be involved in excitation-contraction (EC) coupling by synchronizing the action potential in the sarcolemmal of the t tubules (11) . Such a role, however, remains controversial (12) . On the other hand, it has been suggested that tetrodotoxin (TTX)-sensitive brain-type Na ϩ channels contribute to automaticity of sinoatrial nodal cells of the mouse heart and may have a role in sinoatrial dysfunction (13) . Recently it was shown that Na V 1.1 and Na V 1.6 are the primary Na ϩ -channel subunits in the rat sinus node and that heart failure results in their down-regulation (14) .
The individual cardiac contributions of Na V 1.1, Na V 1.3, and Na V 1.6 were not distinguished in previous studies, which were carried out in wild-type animals expressing all 3 neuronal channels.
Several global-null mutants of Scn8a lacking the Na V 1.6 channel in all tissues have been described (15) . Na V 1.6-null mice exhibit neurological deficits, including tremor, ataxia, and hindlimb paralysis, and do not survive beyond 3 wk of age. Impaired repetitive firing has been shown in cerebellar Purkinje cells and other types of neurons. Reduced size of the heart was described in the null mutant Scn8a dmu , but electrophysiological studies of cardiac function were not carried out (16, 17) . We have used the ENU-induced null mutant Scn8a S21P (18) to determine the consequences of Na V 1.6 reduction on cardiac electrical function and EC coupling. In the ataxia 3 mutant mice, chromosomal mapping of the mutant phenotype and allelism testing demonstrated that the mutation is an allele of Scn8a (18) . Sequencing of the Scn8a brain transcript identified the nucleotide change that resulted in the amino acid substitution S21P (18) . The effect of this mutation is to trap the Nav1.6 protein in the Golgi, resulting in the absence of channel activity (18) . Our approach utilized biochemistry, calcium imaging, patch clamping, and optical mapping to test the hypothesis that Na V 1.6 participates in EC coupling and represents an intrinsic depolarizing reserve that contributes to the maintenance of cardiac excitation.
MATERIALS AND METHODS

Animals
Experiments were carried out with the approval of the Unit of Laboratory Animal Resources at the University of Michigan. Wild-type (WT) littermate and null mice between 19 and 21 d of age were used in this study. Before removal of the heart via thoracotomy, the mice were heparinized (5 U/g, i.p.) and then deeply anesthetized with Avertin (0.05 ml/g, i.p.).
Na V 1.6 mRNA analysis by RT-PCR and sequencing
Hearts were removed and washed in RNase/DNase free ice-cold PBS. Isolated hearts were saved in RNA stabilizing agent (Ambion, Austin, TX, USA) until further use. For isolated cells, the myocytes were allowed to attach on laminincoated dishes for 2 h to remove nonmyocytes. After 2 h, cardiac myocytes were washed with PBS and lysed with lysis buffer to isolate RNA and analyze the expression of Na V 1.6 transcript. Isolated RNA was treated with DNase. cDNA was synthesized from 2 g of total RNA with Oligo dT primers using the SuperScript III First-Strand Synthesis System from Invitrogen (Carlsbad, CA, USA) and then subjected to PCR using Clontech titanium taq PCR Kit (Clontech, Mountain View, CA, USA). Sense (5Ј-AAGTGGACAGCCTATGGCTTCGTC-3Ј) and antisense (5Ј-AGCCAGAAGATGAGACACACCAGC-3Ј) primers (5 pmol) for Na V 1.6 were used in PCR. These primers terminate on nucleotides that are specific for this member of the sodium-channel family and amplify a cDNA fragment containing exons [17] [18] [19] . No-template controls and no-RT controls were run during each experiment to detect any RNA and/or DNA contamination. Samples were denatured at 94°C for 1 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 60°C for 30 s, and extension at 68°C for 1 min, then a final extension at 68°C for 3 min. The PCR product (5 l) was analyzed on a 2% agarose gel by electrophoresis. The PCR product was cleaned and sequenced using above-mentioned primers for Na V 1.6 at the University of Michigan DNA sequencing core.
Mouse ventricular myocyte isolation
On removal of the heart, we proceeded with the enzymatic digestion of the lower 2/3 ventricular region (apex), as described previously (19) . Myocytes were resuspended in buffer containing 10% bovine calf serum and CaCl 2 (12.5 M), and [Ca 2ϩ ] was increased to 1 mM. Cells were used for morphological assessment, immunohistochemistry, electrophysiological recording, and Ca 2ϩ imaging within 8 h after isolation.
Cell size measurement
Morphological measurements (length, width) of plated cells were collected using digital photomicroscopy and the imaging program AxioVision (Zeiss) on a Zeiss inverted microscope with a ϫ10 or ϫ20 objective (Carl Zeiss, Oberkochen, Germany). No significant differences were observed in length or width between live and fixed cells for any of the groups; all subsequent measurements were then conducted on fixed cells. Cells were selected for measurement if they showed no obvious sign of damage.
Immunocytochemistry
Isolated cells were plated on laminin-coated glass coverslips, fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% Triton X-100, and washed with PBS. For sections, hearts were incubated in 30% sucrose solution overnight at 4°C. Endogenous mouse immunoglobulin was blocked using a mouse-on-mouse (anti-mouse Ig) blocking reagent (M.O.M. kit; Vector Laboratories, Burlingame, CA, USA) for 1 h at room temperature. Cells were further blocked for 1 h with 5% normal donkey serum in PBS (containing 0.1% Triton X-100), and subsequently incubated with primary antibodies overnight at 4°C. After washing, donkey secondary antibodies (anti-mouse and anti-rabbit) conjugated to DyLight fluorophores (488, 549; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) were added for 1 h. Nuclei were stained with 100 M 4Ј-6-diamidino-2-phenylindole (DAPI) and washed, and coverslips were mounted to microscope slides using ProLong Gold AntiFade Mounting Kit (Molecular Probes, Eugene, OR, USA).
Immunofluorescence was examined with a Nikon Eclipse Ti inverted confocal microscope with a ϫ63/1.2-NA oil objective (Nikon Inc., Tokyo, Japan), at ambient temperature. Nonconfocal images were obtained using conventional fluorescence with the Apotome system (Zeiss). The antibodies used were rabbit anti-Na V 1.6 (Alomone, Jerusalem, Israel) and monoclonal anti-sarcomeric alpha actinin (Sigma-Aldrich, St Louis, MO, USA). In neurons from Scn8a-null mice, the Alomone antibody cross-reacts with the other abundant neuronal sodium channels (18) , but in cardiomyoctes, we observed specific staining of Na V 1.6 (see below).
clamp (Axopatch 700B amplifier; Axon Instruments, Foster City, CA, USA); settings and properties have been described elsewhere (20, 21) . In one set of experiments, I Na was measured in low [Na ϩ ] o (5 mM) to reduce I Na and improve voltage control. Low-resistance (1.6Ϯ0.1 M⍀) patch pipettes were used. Access resistance was compensated to 1-2 M⍀. Input resistance was 0.4 -1 G⍀. Appropriate whole-cell capacitance and series resistance compensation were applied, along with leak subtraction. Brain-type sodium channels have steady-state inactivation and activation curves between 15 and 25 mV more positive than Na V 1.5 (22) . Thus, brain-type sodium channels have greater availability at depolarized ranges of membrane potential. For I-V relationships, cells were held at different holding potentials (HP; Ϫ120 and Ϫ70 mV) and stepped to a range of potentials (Ϫ100 to ϩ30 mV in 5-mV increments for HPϭϪ120 mV, and Ϫ60 to ϩ30 mV for HPϭϪ70 mV) for 100 ms each. In a second set of experiments, 100 nM TTX-sensitive sodium currents (braintype isoforms) were measured at 50 mM [Na ϩ ] o and at the holding potential of Ϫ70 mV, in the presence of 1 mM Cd 2ϩ to selectively block Na V 1.5 (23) . In a subset of these experiments, [TTX] was increased to 1 M.
ECG recording
Lead II ECG in restrained, conscious animals was recorded and digitized (1.2 kHz) using custom-made software in LabView (National Instruments, Austin, TX, USA) and a Biopac Systems amplifier (DA100C) and digitizer (IPS100C; Biopac Systems, Santa Barbara, CA, USA).
Optical mapping of the whole heart
The heart was rapidly excised through thoracotomy, connected to a Langendorff-perfusion system, and perfused with warm oxygenated Tyrode's solution as described earlier (24 -26) and allowed to equilibrate for 10 min. We used Di-4-ANEPPS and a CCD camera (64ϫ64 pixel; spatiotemporal resolution 109 m, 1 kHz) and mapped the epicardial anterior surfaces of the ventricles. Further details have been presented elsewhere (24 -27) . Here, 7 M blebbistatin was used to prevent contraction. Sixteen WT and 17 null hearts were initially perfused with 4 mM [K ϩ ] o Tyrode's solution. In a subset of 9 hearts in both phenotyopes, the [K ϩ ] o was raised to 8, 10, and 12 mM, for 15 min at each [K ϩ ] o . At the ends of the 15-min periods, pacing was done with a bipolar, silver-tip stimulation electrode placed on the apex (3-ms pulses, ϫ2 diastolic threshold, cycle lengths of 140 and 80 ms), and movies were recorded. We generated activation and APD maps by calculating, for each pixel, the activation time or the APD at 80% repolarization during pacing at 140 and 80 ms. To compute CV, the magnitude of local conduction vectors was determined on the basis of the activation times of surrounding pixels as described elsewhere (24) .
Calcium imaging
Briefly, cell suspensions were incubated with cell-permeant rhod-2AM calcium indicator (10 M; Molecular Probes) for 10 min at room temperature and then washed to remove excess dye. Fluorescence was expressed as ⌬F/F 0 ϭ (F Ϫ F 0 / F 0 ), where F is the fluorescence at any given time and F 0 is the baseline fluorescence value. Nonconfocal calcium was imaged at 200 Hz in individual cells using an inverted Zeiss microscope equipped with temperature control and a Redshirt Imaging camera (Redshirt Imaging, Decatur, GA, USA). The cells were paced at 1 Hz.
Statistics
One-way ANOVA with Bonferroni correction and t test were used as appropriate. For the hyperkalemia experiments, we used the Multivariate Mixed procedure in the SAS package (SAS Institute, Cary, NC, USA) in consultation with the University of Michigan Center for Statistical Consultation and Research. We indicate in the text and figure legends the statistical test used and whether data are averages Ϯ se or sd.
RESULTS
Morphological assessment
Macroscopic examination revealed that Na V 1.6-null hearts were small compared with WT littermates at 18 d of age. Previous studies noted that the reduction in heart size is proportional to the overall reduction in body weight (16, 17) . Since Na V 1.6 is a neuronal sodium channel, we investigated whether the nerve supply to the ventricles was altered in the null hearts compared to WT littermates using acetylcholinesterase precipitation reaction (28) . Macroscopically, the epicardial innervation of 4 null hearts did not appear to be altered when compared with 4 WT hearts (data not shown). On the other hand, the ventricular myocytes of the null mouse (Fig. 1Ab) were appreciably smaller than those of WT littermates (Fig. 1Aa) . Morphometric quantification demonstrated that the ventricular cardiomyocytes of 4 null hearts had significantly reduced length (Fig. 1Ac) and width (Fig. 1Ad ) compared to 3 WT hearts. Figure 1B compares representative confocal images of the t-tubule network of littermate WT and null myocytes. The images of these live myocytes were stained with wheat-germ agglutinin (Fig. 1Ba, b) or the lipophilic dye di-8-ANEPPS (Fig. 1Bc, d) . Figure 1Be , f shows fluorescence intensity profiles along the longitudinal axis of each cell stained with di-8-ANEPPS. Figure  1Bg , h shows the respective spectra obtained by fast Fourier transformation of the fluorescence profiles. The t-tubule network is apparent in both WT and null cardiomyocytes, with a regular fluorescence profile (peaks at ϳ2 m intervals). This pattern was similar in cells from 3 WT and 3 null hearts and is consistent with other studies in rodents (29) . In addition, membrane capacitance was decreased in null (72Ϯ2.3 pF) compared to WT (83Ϯ5.4 pF; P Ͻ 0.05; Nϭ4, nϭ10); the resting membrane potential in WT was Ϫ77.25 Ϯ 0.76 (Nϭ3, nϭ6) and in null Ϫ75.13 Ϯ 1.18 (Nϭ3, Nϭ6).
Characterization of Scn8a transcripts in the heart
The Scn8a gene contains alternative exons 18N and 18A that exhibit tissue-specific splicing (30) . Transcripts containing exon 18A encode the full-length channel and in previous studies were shown to be restricted to brain. Because of the in-frame stop codon in exon 18N, transcripts in non-neural cells encode a truncated, 2-domain protein (30) . This alternative splicing pattern was thought to restrict active Na V 1.6 channels to neu-rons; however, Scn8a transcripts in heart have not previously been characterized. To specifically amplify Na V 1.6 transcripts in the presence of Na V 1.5 and the other brain-type channels, we designed a gene-specific forward primer in exon 17 and reverse primer in exon 19 terminating in nucleotides that differ between Na V 1.6 and the other sodium channels. Using these primers, we detected 3 Scn8a transcripts in heart containing exon 18A, exon 18N, or skipping both (⌬18; Fig. 2A ). The inclusion of exon 18A was confirmed by sequencing the PCR product isolated from the gel. This is the first demonstration that Na V 1.6 transcripts encoding full-length protein are expressed in the heart and provides important validation for the detection of Na V 1.6 by immunostaining (see below). We also examined Na V 1.6 transcripts in isolated adult cardiomyocytes. PCR products from isolated myocytes, whole heart, and brain were amplified from 100 ng of RNA (Fig. 2B ). These data demonstrate directly that fulllength Na V 1.6 transcripts are present in the ventricular myocytes.
Immunolocalization of Na V 1.6
Previous studies reported that Na V 1.6 protein is localized to the t tubules of the mouse cardiac myocyte, but these studies did not include the null control to confirm the specificity of immunostaining (9, 11) . After confirming the presence of the full-length coding transcript of Scn8a in the heart, we conducted immunolocalization experiments on WT and mutant heart. Immunofluorescence in single cells from WT heart confirmed the localization of Na V 1.6 in a t-tubular pattern (Fig. 3A, left panel) . Na V 1.6 immunofluorescence is shown in red, and ␣-sarcomeric actinin staining is shown in green. In WT, but not null, myocytes, Na V 1.6 exhibits a striated staining pattern that colocalizes with ␣-actinin (Fig. 3A) . In Scn8a-null myocytes, no specific staining pattern is observed with antibodies for Na V 1.6 although actinin staining is normal (Fig. 3A,  right panel) . In addition, the intensity profiles along the indicated arrows (Fig. 3A) show that Na V 1.6 fluorescence pattern colocalizes with that of actinin in an alternating manner, demonstrating the presence of Na V 1.6 in the t tubules of the WT, but not in the null myocyte. The confocal microscope laser settings were identical for all images.
Functional expression of Na V 1.6 in the mouse heart
As an initial approximation to estimate the contribution of Na V 1.6 to I Na in cardiac ventricular myocytes, we compared the I-V relations of WT vs. null ventricular myocytes at 5 mM [Na ϩ ] o and 2 different HPs: Ϫ120 mV (Fig. 4A) and Ϫ70 mV (Fig. 4B) . Our rationale for these experiments was based on the fact that the range of inactivation voltages of brain-type Na ϩ channels is significantly more positive than Na V 1.5 (3, 22) ; therefore, at Ϫ70 mV, the Na V 1.5 channels are largely inactivated. In Fig. 4A , at HP ϭ Ϫ120 mV and 5 mM [Na ϩ ] o , peak inward I Na was similar in the two phenotypes. However, at HP ϭ Ϫ70 mV (Fig. 4B) , the peak inward I Na was smaller in null compared to WT cells (3Ϯ0.3 pA/pF, Nϭ2, nϭ4 vs. 5.5Ϯ0.28 pA/pF, Nϭ2, nϭ5, PϽ0.05, ANOVA). To further distinguish between Na V 1.5 and Na V 1.6, we used the channel blocker TTX. Brain-type Na ϩ channels, including Na V 1.6, are sensitive to nanomolar blocking concentrations (100 nM) of TTX, whereas cardiac-type channels require TTX concentrations in the micromolar range to be fully blocked (20, 21) . On the other hand, Na V 1.5 can be readily blocked by Cd 2ϩ at much lower concentrations than brain-type Na ϩ channels (23) . Therefore, we conducted a second set of experiments to compare the density of the TTX-sensitive I Na in WT vs. null myocytes in the continuous presence of 1 mM Cd 2ϩ , which enabled us to raise the [Na ϩ ] o to 50 mM, while still maintaining voltage control. Before TTX, the peak inward I Na was significantly smaller in null cells (Fig.  4D ) than WT cells ( Fig. 4C; 3 .4Ϯ0.6 pA/pF, Nϭ5, nϭ9 vs. 8.9Ϯ1 pA/pF, Nϭ4, nϭ10, PϽ0.05, ANOVA). After addition of 100 nM TTX, the peak currents decreased to 1.5 Ϯ 0.5 pA/pF in null myocytes (Fig. 4D ) and 3.4 Ϯ 0.4 pA/pF in WT (PϽ0.05; Fig. 4C ). After addition of 1 M TTX, the current was reduced to 1.5 Ϯ 0.04 pA/pF (Nϭ2, nϭ4) and 1.2 Ϯ 0.01 pA/pF (Nϭ3, nϭ5) in WT and null myocytes, respectively. The V 1/2 of inactivation in WT and null myocytes was Ϫ72.2 and Ϫ73.1 mV, respectively, and the slope factor was the same in both phenotypes at 9.3 (Fig. 4E) . For activation, the V 1/2 and the slope factor in WT and null myocytes were Ϫ26.8 mV and 27.9 (Fig. 4E) . In Fig. 4F , the 100 nM TTXsensitive current obtained from the data in Fig. 4C , D was significantly smaller in null than WT cells (2.6Ϯ0.5 pA/pF vs. 5.8Ϯ0.7 pA/pF, PϽ0.05, ANOVA). Altogether, these experiments support the presence of functional Na V 1.6 channels in the mouse ventricular myocytes.
Reduced Na V 1.6 results in an altered ECG phenotype
We recorded ECGs (lead II) in nonanesthetized, gently restrained conscious WT and null mice. Figure 5A shows representative recordings of a single sinus beat in a WT mouse (left panel) and in a null mouse (right panel). The PR interval is prolonged and the QRS is wider in the null mouse. Superposition of QRS-T complexes from mice in Fig. 5B illustrates the QRS prolongation in the Na V 1.6 mutant mouse. The bar graph in Fig. 5C quantifies the PR and QRS intervals from 8 WT and 9 null mice. Both intervals were prolonged in the Na V 1.6 mutant animals. The PR interval was 30 Ϯ 3.7 ms in null, compared with 42 Ϯ 6.7 ms in WT (P Ͻ 0.05), and the QRS was 15 Ϯ 3.8 ms in WT compared with 20 Ϯ 1.2 ms in null (PϽ0.05, ANOVA).
Na V 1.6 contributes to conduction velocity and action potential duration in the normal mouse ventricles
In isolated WT and null hearts, we determined the epicardial conduction velocity (CV) and action potential duration (APD) on the anterior surface of the ventricles. Hearts were Langendorff perfused with 4 mM K ϩ Tyrode's solution and paced from the apex. Measurements at 2 different cycle lengths (CLs), 140 and 80 ms, demonstrated small but significant differences in both CVs between the two groups. At CL ϭ Hyperkalemia exaggerates the slowing of CV in Na V 1.6-null mouse hearts
Brain-type sodium channels have more positive activation threshold and greater availability at depolarized ranges of membrane potential than Na V 1.5. We therefore surmised that brain-type sodium channels, including Na V 1.6, may play a role in helping to maintain impulse conduction in depolarized hearts and that the loss of Na V 1.6 should result in a significantly greater reduction of CV than in normally polarized hearts. In 8 WT and 9 null hearts (each heart measured twice), CV was quantified at pacing CL of 140 ms in 4, (Fig. 6) (31) . Most important, they demonstrate that the absence of Na V 1.6 causes a CV defect in the presence of hyperkalemia. It is important to note that due to the smaller number of animals in this experimental subset (8 WT and 9 null), difference in CV was not significant at 4 mM K ϩ compared to the significant reduction we observed at 4 mM K ϩ in 16 WT and 17 null hearts described in the previous section.
Extracellular potassium and APD
We also quantified the effects of hyperkalemia on APD 80 (Fig. 7) . Similarly to CV, APD 80 APD 80 
. APD 80 increased progressively in both cases, but the increase was significantly steeper for the null hearts. Figure 7C shows APD 80 vs. [K ϩ ] o at pacing CL of 80 ms.
Na V 1.6 deletion alters Ca 2؉ transient duration
Brain-type Na ϩ channels, including Na V 1.6, localize to the t tubules of the ventricular myocyte (ref. 11 and Fig.  3 ). Some researchers have suggested that brain-type sodium channels contribute to a more effective Ca 2ϩ -induced Ca 2ϩ release, and consequently to a more efficient contraction, but the idea is controversial (12) . We compared the Ca 2ϩ transient duration in WT vs. null myocytes during pacing at 1Hz. The left panel of Fig. 8A shows the change in fluorescence along the longitudinal red line on the cartoon of a myocyte. Time-space plots (Fig. 8A, center panel) . This experiment shows that calcium cycling is altered in Na V 1.6 mutant mouse hearts. Whether this is caused by APD prolongation, or because removal of the Nav1.6 from the t tubules causes inefficient and asynchronous calcium cycling and consequently prolongs APD, remains to be determined. Both scenarios are possible. It should also be noted that recently Torres et al. (32) showed that neuronal sodium channels contribute to triggering Ca 2ϩ release from the sarcoplasmic reticulum in rabbit ventricular myocytes.
DISCUSSION
The most important results of our study may be summarized as follows: the Na V 1.6 transcript encoding the full-length protein is expressed in the mouse ventricles, and the protein is localized mainly in the t tubules of the myocyte; in the NaV1.6-null mice, ventricular myocytes are smaller than in WT, and the TTX-sensitive sodium current is significantly reduced; PR and QRS intervals, as well as ventricular APD, are prolonged in the null mice; at 4 mM [K ϩ ] o , epicardial conduction velocity is slightly reduced, but in hyperkalemia (10 and 12 mM [K ϩ ] o ) CV slowing is exaggerated in the null mouse heart; and finally, the calcium transient duration is longer in the null than WT myocytes.
Altogether, the results strongly support the hypothesis that Na V 1.6 plays a role in excitation and propagation. Because of its larger availability at more positive membrane potentials compared to the cardiac type Na V 1.5 isoform, Na V 1.6 may contribute to maintaining the integrity of the action potential propagation when the resting membrane potential is depolarized, such as in hyperkalemia. In addition, because of their localization at the t tubules, Na V 1.6 channels likely participate in EC coupling by accelerating the depolarization of the sarcolemmal membrane, and thus synchronizing the calcium-induced calcium-release events.
Na V 1.6 channels are encoded by the SCN8A gene, which was originally identified by positional cloning of a mouse mutant (33) . When expressed in nonexcitable cells in culture, the voltage-dependent activation and fast inactivation properties of Na V 1.6 are similar to Na V 1.2, but its voltage dependence of slow inactivation is more positive than other brain-type Na ϩ channels (22) . Estimates using various pharmacologic strategies indicate that between 5 and 8% of the total cardiac I Na originates from brain-type TTX-sensitive sodium channels in ventricular myocytes in mice (11, 20, 21) , 11% in rats, and 10% in dogs, (20) , and 20% in cardiac Purkinje cells in dogs (20) . The Catterall laboratory (11) has recorded neuronal Na ϩ current in cardiac myocytes using a scorpion toxin activator of these channels. However, to our knowledge, our study is the first to focus on the specific role played by Na V 1.6 in cardiac electrical function using genetically altered mice. Since brain-type sodium channels, particularly Na V 1.6, display a greater availability than Na V 1.5 at positive potentials (3) they are adequately suited to maintain excitability in the more depolarized cardiac muscle. This is clearly the case in isolated Na V 1.6 mutant mice exposed to high extracellular potassium concentrations (Fig. 6 ). In addition, it is reasonable to surmise that the unusually large late component of the sodium current of Na V 1.6 (22) contributes to APD in the heart. However, APD is prolonged in the null mice. Such a counterintuitive prolongation may be brought about by potassium-channel remodeling, such as the transient outward current I to , I KSlow, the sustained current I Ksus , or the inward rectifier current I K1 . It could also be a response to the prolonged Ca 2ϩ transient and the activation of the Na-Ca exchange current.
Brain-type sodium channels and EC coupling
Maier et al. (11) demonstrated that nanomolar concentrations of TTX interfered with left ventricular contractile function. The researchers proposed that brain-type sodium channels play a role in coupling depolarization of the cell surface membrane to contraction. Torres et al. (32) also suggested that neuronal sodium channels are important for EC coupling in the rabbit ventricular myocyte. Other researchers disagree (12) . Our experiments in Na V 1.6 mutant mice clearly show a prolongation of the Ca 2ϩ transient duration (Fig. 8) , indicating some kind of EC coupling disruption. Additional work is required to investigate these issues. The prolongation of the calcium transient in the Na V 1.6-null mice opens new avenues for research into its underlying mechanisms. It may be caused by delays in the triggering of Ca 2ϩ release (29) , late-opening LCCs, slowly propagating calcium induced calcium release waves, or slowed reuptake of cytosolic Ca 2ϩ due to changes in the SERCA pump, phospholamban, or the sodium calcium exchanger.
Pathophysiological implications
TTX-sensitive brain-type Na ϩ channels appear to contribute to automaticity of sinoatrial nodal cells of the mouse heart and may have a role in sinoatrial dysfunction (13) . Recently it was shown that Na V 1.1 and Na V 1.6 are the primary Na ϩ -channel subunits in the rat sinus node and that heart failure results in their downregulation (14) . Missense mutations of neuronal Na ϩ -channel genes have been linked to epilepsy, chronic pain, and migraine, and Ͼ700 mutants of Nav1.1 have been identified in patients with epilepsy (4, 34, 35) . In many cases, the defect not only increases the late component of the current in neurons but may also have life-threatening consequences in the heart because of prolongation of the QT interval (3), although no direct link between LQT and neuronal sodium-channel mutations has been made. It is interesting that QT prolongation is thought to be a major mechanism leading to sudden unexpected death in epilepsy (36) . In addition, ictal atrioventricular block is a common finding in patients with epilepsy, and QT dispersion, a risk indicator of cardiac arrhythmias, is significantly increased on ECG of children with epilepsy (3). A heterozygous null mutation of human Na V 1.6 was identified in a family with ataxia and cognitive impairment (5); however, it is not known whether the patients present a cardiac phenotype. Our results provide the first direct demonstration that a brain-type sodium-channel mutation that results in severe ataxia in the mouse also has cardiac consequences, including alterations in cardiac impulse conduction and EC-coupling synchrony. Whether those cardiac consequences are significant in patients with equivalent brain-type mutations remains to be determined.
Limitations
Many differences exist between ion channels that underlie the action potential waveforms in rodents and humans, which calls for extreme caution before attempting to extrapolate our results. Our analysis has been restricted to very young mice because of the lethality of the Na V 1.6-null mutation at 3 wk of age (18) . In addition, the global Na V 1.6-null mice may exhibit secondary effects on the heart, such as lateralization of connexin43, possible compensatory changes in other neuronal sodium channels, or adaptive remodeling due to the decreased body size of the null mice. For these reasons, development of a heart-specific Na V 1.6-KO mouse model should be valuable for confirming the cell-autonomous role of Na V 1.6 in cardiomyocytes and characterization of Na V 1.6 deficiency in the adult heart.
CONCLUSIONS
The demonstration that brain-type Na ϩ channels are expressed in various proportions in the heart, and that they contribute to function in most cardiac tissues, including sinoatrial node, (13) ventricles (11, 12, 21) , and cardiac conduction system, (20) has opened new and exciting pathways for research into the molecular basis of cardiac excitability and arrhythmogenesis in both cardiac and brain diseases. Characterization of new models of brain-type ion-channel diseases in mice offers unique opportunities to better understand the molecular mechanisms of cardiac disease pathogenesis associated with imbalances of specific ion-channel isoforms. Previous functional studies of the brain-type channels in heart have relied on the pharmacological distinction between cardiac and brain channels, (3), based on the greater sensitivity of the brain channels to TTX compared to the cardiac Na V 1.5 channels. However, TTX sensitivity does not distinguish among the brain channels Na V 1.1, Na V 1.3, and Na V 1.6, all of which seem to be expressed in the heart. Our demonstration of a cardiac phenotype in Na V 1.6-null mice provides the first direct evidence for the importance of Na V 1.6 in EC coupling and in the maintenance of ventricular conduction velocity and possibly under conditions in which the resting membrane potential is depolarized and cardiac excitability is jeopardized.
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